With its outstanding investment team and unique multimanager approach, Vanguard Capital Opportunity is exemplary.
Vanguard Capital Opportunity Adm VHCAX
- NAV / 1-Day Return 184.70 / −0.50 %
- Total Assets 22.5 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.360%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 50,000
- Status Limited
- TTM Yield 0.69%
- Turnover 6%
USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:21 PM GMT+0
Morningstar’s Analysis VHCAX
Will VHCAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 9.47 | 2.0 Bil | Healthcare |
Mktliq 12/31/2049 | 4.06 | 851.5 Mil | Cash and Equivalents |
Amgen Inc | 2.91 | 611.1 Mil | Healthcare |
Biogen Inc | 2.76 | 580.1 Mil | Healthcare |
Microsoft Corp | 2.51 | 526.9 Mil | Technology |
Biomarin Pharmaceutical Inc | 2.47 | 517.9 Mil | Healthcare |
Flex Ltd | 2.18 | 457.8 Mil | Technology |
KLA Corp | 2.11 | 443.9 Mil | Technology |
Micron Technology Inc | 2.02 | 423.5 Mil | Technology |
FedEx Corp | 1.99 | 417.2 Mil | Industrials |